Keyphrases
Advanced Stage
6%
Clinical Centers
40%
Clinical Drug Trials
8%
Clinical Follow-up
14%
Clinical Trials
71%
Disease Stage
6%
General Neurologists
6%
Georgia
46%
Health Sciences
28%
Local Area
6%
Medical Colleges
18%
Medication Use
20%
Movement Disorders
26%
NET-PD
28%
Neuroprotection
71%
Neuroprotective
6%
Neuroprotective Potential
28%
Newly Diagnosed
6%
NINDS
14%
Ongoing Clinical Trials
14%
Parkinson Patients
12%
Parkinson's Disease
71%
Patient Demographics
6%
Patients with Parkinson's Disease
6%
PD Programmes
21%
Pharmacological Agents
14%
Placebo
14%
Placebo-controlled Clinical Trial
14%
Primary Care Providers
6%
Quality of Life
14%
Seeking Support
14%
Specific Intent
6%
Successful Completion
14%
Support Groups
12%
Veterans Affairs Medical Center
12%
Medicine and Dentistry
Base
6%
Clinical Trial
100%
Controlled Clinical Trial
21%
Disease
78%
Drug Therapy
27%
Neuroprotection
100%
Neuroprotective Agent
49%
Parkinson's Disease
100%
Patient Population
6%
Patient Referral
6%
Placebo
42%
Primary Health Care
6%
Quality of Life
21%
Stereotypic Movement Disorder
34%
Veterans Affairs
12%
Pharmacology, Toxicology and Pharmaceutical Science
Base
6%
Clinical Trial
100%
Controlled Clinical Trial
21%
Disease
78%
Motor Dysfunction
34%
Neuroprotection
100%
Neuroprotective Agent
49%
Parkinson's Disease
100%
Placebo
42%